Population-level study provides reassuring data on the risk of kidney disease relapse after COVID-19 vaccination

Specialist researcher holding microscope slide analyzing blood sample working at coronavirus vaccine development during virus examination in microbiology hospital laboratory. Biochemistry experiment

Several reports have described a relapse of certain autoimmune kidney diseases in patients after they’ve received COVID-19 vaccines, but it’s unclear if this association is real or a coincidence. In a recent population-level study published in Journal of the American Society of Nephrology (JASN), investigators found that a second or third dose of COVID-19 vaccine was associated with higher relative risk but low absolute increased risk of disease relapse.

LEGO sets, Barbies, Squishmallows, and more toys are already on sale ahead of Black Friday

Previous article

Novel monoclonal antibodies NA8 and NE12 can neutralize most SARS-CoV-2 variants and Omicron subvariants

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations